CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 186 filers reported holding CYTOKINETICS INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,568,000 | +11.2% | 800,000 | +23.1% | 3.26% | +24.3% |
Q2 2023 | $21,203,000 | +0.4% | 650,000 | +8.3% | 2.62% | -38.3% |
Q1 2023 | $21,114,000 | +15.2% | 600,000 | +50.0% | 4.25% | +10.6% |
Q4 2022 | $18,328,000 | +8.1% | 400,000 | +14.3% | 3.85% | +16.8% |
Q3 2022 | $16,958,000 | -17.8% | 350,000 | -33.3% | 3.29% | -22.4% |
Q2 2022 | $20,627,000 | +19.2% | 525,000 | +11.7% | 4.24% | -5.8% |
Q1 2022 | $17,301,000 | +16.8% | 470,000 | +44.6% | 4.50% | +9.8% |
Q4 2021 | $14,814,000 | +27.5% | 325,000 | 0.0% | 4.10% | +22.8% |
Q3 2021 | $11,616,000 | -16.1% | 325,000 | -53.6% | 3.34% | -12.5% |
Q2 2021 | $13,853,000 | -14.9% | 700,000 | 0.0% | 3.81% | -18.0% |
Q1 2021 | $16,282,000 | +49.2% | 700,000 | +33.3% | 4.65% | +43.4% |
Q4 2020 | $10,910,000 | +152.0% | 525,000 | +162.5% | 3.24% | +145.1% |
Q3 2020 | $4,330,000 | -46.0% | 200,000 | -41.2% | 1.32% | -44.8% |
Q2 2020 | $8,014,000 | +112.4% | 340,000 | +6.2% | 2.40% | +44.4% |
Q1 2020 | $3,773,000 | – | 320,000 | – | 1.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |